Clinical Research Advances in Endometrial Carcinoma

Dear Colleagues,

Endometrial cancer (EC) is the most common gynecologic malignancy in industrialized nations, and its incidence is increasing globally. Although EC is diagnosed at an early stage, about 20% of early-stage EC patients present poor outcomes. Furthermore, although the overall survival (OS) of EC patients is known to be relatively good, 10–15% of patients with low-risk EC experience a recurrence, while about 50% of patients with high-risk EC do not. For these reasons, there is a growing interest in a better understanding of genetic diversity, as well as a trend toward a more personalized diagnosis, surgical approach, adjuvant therapy, oncological surveillance, and the development of new and molecularly integrated protocols to manage endometrial cancer.

The Special Issue will focus on epidemiology, pathophysiology, diagnosis, molecular classification, and recent advancements in disease management.

Dr. Salvatore Lopez
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• endometrial cancer
• uterine serous carcinoma
• immunotherapy
• MMRd
• POLE
• endometrioid carcinoma
• target therapies
• surgery
• preclinical research